Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors

por Kovesdy, Csaba, Schmedt, Niklas, Folkerts, Kerstin, Bowrin, Kevin, Raad, Hanaya, Batech, Michael, Fried, Linda
Publicado 2022

High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database

por Fried, Linda, Schmedt, Niklas, Folkerts, Kerstin, Bowrin, Kevin, Raad, Hanaya, Batech, Michael, Kovesdy, Csaba
Publicado 2022

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease

por Folkerts, Kerstin, Millier, Aurelie, Smela, Beata, Olewinska, Elzbieta, Schmedt, Niklas, Mernagh, Paul, Kovesdy, Csaba P.
Publicado 2022

Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database

por Folkerts, Kerstin, Petruski-Ivleva, Natalia, Kelly, Amanda, Fried, Linda, Blankenburg, Michael, Gay, Alain, Kovesdy, Csaba P
Publicado 2020

Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study

por Kovesdy, Csaba P, Isaman, Danielle, Petruski-Ivleva, Natalia, Fried, Linda, Blankenburg, Michael, Gay, Alain, Velentgas, Priscilla, Folkerts, Kerstin
Publicado 2020

Patient-Reported Treatment Experience with Oral Rivaroxaban: Results from the Noninterventional XALIA Study of Deep-Vein Thrombosis

por Cano, Stefan, Mantovani, Lorenzo, Folkerts, Kerstin, Gebel, Martin, Sahin, Kurtulus, Zell, Elizabeth, Monje, Danja, Schneider, Jonas, Eickels, Martin van, Haas, Sylvia, Kreutz, Reinhold, Ageno, Walter, Turpie, Alexander G. G.
Publicado 2018